title: Can we Modulate the Autonomic Nervous System to Improve the Life of Patients with Heart Failure? The Case of Vagal Stimulation.
abstract: An imbalance of the autonomic nervous system, with reduced vagal and increased sympathetic activity, contributes to pathogenesis and clinical deterioration in heart failure (HF). Experimental studies have demonstrated that vagal stimulation (VS) has an antifibrillatory effect that has proved beneficial in animal models of HF. The potential value of chronic VS in man was first investigated with an implantable neuro-stimulator capable of delivering low current pulses with adjustable parameters to stimulate the right vagus. The results of a pilot study and a small multicentre clinical trial of VS in HF patients appeared to show a favourable clinical effect, and feasibility and safety data were encouraging. An ongoing pivotal clinical trial will provide a definitive assessment of the efficacy and usefulness of chronic VS in HF patients.This approach represents a new and exciting possibility for the management of HF that will provide clinicians with a novel tool to modulate non-pharmacologically the autonomic nervous system in patients with moderate-to-advanced HF.
authors.affiliation: Professor and Head, Centre for Cardiac Arrhythmias of Genetic Origin, IRCCS Istituto Auxologico Italiano, Milan, Italy.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Schwartz
keywords: Heart failure; autonomic nervous system; vagal stimulation
references.citation: Circ Res. 1973 Feb;32(2):215-20
references.pmid: 4685965
references.citation: Eur Heart J. 2011 Apr;32(7):847-55
references.pmid: 21030409
references.citation: Circ Heart Fail. 2009 Nov;2(6):692-9
references.pmid: 19919995
references.citation: Circulation. 2004 Jan 6;109(1):120-4
references.pmid: 14662714
references.citation: Lancet. 1998 Feb 14;351(9101):478-84
references.pmid: 9482439
references.citation: Circulation. 1999 Jun 8;99(22):2958-63
references.pmid: 10359742
references.citation: Circ Res. 1991 May;68(5):1471-81
references.pmid: 2019002
references.citation: Europace. 2014 Jan;16(1):109-28
references.pmid: 24265466
references.citation: Circulation. 2009 Apr 14;119(14):e391-479
references.pmid: 19324966
references.citation: Eur J Heart Fail. 2008 Sep;10(9):884-91
references.pmid: 18760668
references.citation: Heart Fail Rev. 2011 Mar;16(2):101-7
references.pmid: 20577900
references.citation: Eur J Heart Fail. 2014 Jun;16(6):692-9
references.pmid: 24846173
references.citation: Circ Heart Fail. 2015 May;8(3):619-28
references.pmid: 25991804
references.citation: Circulation. 1997 Nov 18;96(10):3450-8
references.pmid: 9396441
references.citation: N Engl J Med. 1984 Sep 27;311(13):819-23
references.pmid: 6382011
references.citation: Circulation. 1988 Oct;78(4):969-79
references.pmid: 3168199
references.citation: Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1780-5
references.pmid: 15191889
references.citation: Am Heart J. 2012 Jun;163(6):954-962.e1
references.pmid: 22709747
references.citation: J Card Fail. 2013 Sep;19(9):655-60
references.pmid: 24054343
references.citation: J Am Coll Cardiol. 2009 Jan 13;53(2):193-9
references.pmid: 19130988
references.citation: Circulation. 1992 Jan;85(1 Suppl):I77-91
references.pmid: 1728509
references.citation: Circulation. 1984 Apr;69(4):790-800
references.pmid: 6697463
references.citation: N Engl J Med. 1971 Oct 14;285(16):877-83
references.pmid: 4398792